The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors.

Autor: Bissonnette, Reid P.1 (AUTHOR), Cesario, Rosemary M.1 (AUTHOR), Goodenow, Bob1 (AUTHOR), Shojaei, Farbod1 (AUTHOR) fshojaei@huyabio.com, Gillings, Mireille1 (AUTHOR)
Zdroj: BMC Cancer. 8/30/2021, Vol. 21 Issue 1, p1-17. 17p.
Databáze: Academic Search Ultimate